Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Multiple Sclerosis and Related Disorders
|
October 29, 2024
Artificial neural network-based prediction of multiple sclerosis using blood-based metabolomics data
Nasar Ata, Insha Zahoor, Nasrul Hoda, et al.
Journal of Neurology & Neurophysiology
|
February 3, 2015
Perfusion and Diffusion Abnormalities of Multiple Sclerosis Lesions and Relevance of Classified Lesions to Disease Status
Lian Li, Michael Chopp, Siamak P Nejad-Davarani, et al.
Biorxiv : the Preprint Server for Biology
|
January 23, 2024
Blood-based targeted metabolipidomics reveals altered omega fatty acid-derived lipid mediators in relapsing-remitting multiple sclerosis patients
Insha Zahoor, Jeffrey Waters, Nasar Ata, et al.
Clinical Case Reports and Reviews
|
November 25, 2017
Resting state fMRI connectivity analysis as a tool for detection of abnormalities in five different cognitive networks of the brain in Multiple Sclerosis patients
Siamak P Nejad-Davarani, Michael Chopp, Scott Peltier, et al.
Biorxiv : the Preprint Server for Biology
|
October 9, 2023
Maresin-1 promotes neuroprotection and prevents disease progression in experimental models of multiple sclerosis through metabolic reprogramming and shaping innate and adaptive disease-associated cell types
Insha Zahoor, Mohammad Nematullah, Mohammad Ejaz Ahmed, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 14, 2022
Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target
Insha Zahoor, Hamid Suhail, Indrani Datta, et al.
The Journal of Biological Chemistry
|
January 26, 2025
Maresin-1 promotes neuroprotection and modulates metabolic and inflammatory responses in disease-associated cell types in preclinical models of multiple sclerosis
Insha Zahoor, Mohammad Nematullah, Mohammad Ejaz Ahmed, et al.
Multiple Sclerosis and Related Disorders
|
March 15, 2026
Multiple sclerosis in the All of Us Research Program: Prevalence and associated demographic and geographic characteristics
Cathryn D Peltz-Rauchman, Ze Meng, Lisiyu Ma, et al.
Journal of the Neurological Sciences
|
September 27, 2020
COVID-19 in multiple sclerosis patients and risk factors for severe infection
Farhan Chaudhry, Helena Bulka, Anirudha S Rathnam, et al.
The Journal of Biological Chemistry
|
November 8, 2015
Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis
Laila M Poisson, Hamid Suhail, Jaspreet Singh, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Multiple Sclerosis and Related Disorders
|
October 29, 2024
Artificial neural network-based prediction of multiple sclerosis using blood-based metabolomics data
Nasar Ata, Insha Zahoor, Nasrul Hoda, et al.
Journal of Neurology & Neurophysiology
|
February 3, 2015
Perfusion and Diffusion Abnormalities of Multiple Sclerosis Lesions and Relevance of Classified Lesions to Disease Status
Lian Li, Michael Chopp, Siamak P Nejad-Davarani, et al.
Biorxiv : the Preprint Server for Biology
|
January 23, 2024
Blood-based targeted metabolipidomics reveals altered omega fatty acid-derived lipid mediators in relapsing-remitting multiple sclerosis patients
Insha Zahoor, Jeffrey Waters, Nasar Ata, et al.
Clinical Case Reports and Reviews
|
November 25, 2017
Resting state fMRI connectivity analysis as a tool for detection of abnormalities in five different cognitive networks of the brain in Multiple Sclerosis patients
Siamak P Nejad-Davarani, Michael Chopp, Scott Peltier, et al.
Biorxiv : the Preprint Server for Biology
|
October 9, 2023
Maresin-1 promotes neuroprotection and prevents disease progression in experimental models of multiple sclerosis through metabolic reprogramming and shaping innate and adaptive disease-associated cell types
Insha Zahoor, Mohammad Nematullah, Mohammad Ejaz Ahmed, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 14, 2022
Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target
Insha Zahoor, Hamid Suhail, Indrani Datta, et al.
The Journal of Biological Chemistry
|
January 26, 2025
Maresin-1 promotes neuroprotection and modulates metabolic and inflammatory responses in disease-associated cell types in preclinical models of multiple sclerosis
Insha Zahoor, Mohammad Nematullah, Mohammad Ejaz Ahmed, et al.
Multiple Sclerosis and Related Disorders
|
March 15, 2026
Multiple sclerosis in the All of Us Research Program: Prevalence and associated demographic and geographic characteristics
Cathryn D Peltz-Rauchman, Ze Meng, Lisiyu Ma, et al.
Journal of the Neurological Sciences
|
September 27, 2020
COVID-19 in multiple sclerosis patients and risk factors for severe infection
Farhan Chaudhry, Helena Bulka, Anirudha S Rathnam, et al.
The Journal of Biological Chemistry
|
November 8, 2015
Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis
Laila M Poisson, Hamid Suhail, Jaspreet Singh, et al.
Page
of 4